Direkt zum Inhalt

Hau, Peter ; Fabel, Klaus ; Baumgart, Ulrike ; Rümmele, Petra ; Grauer, Oliver ; Bock, Annekatrin ; Dietmaier, Christopher ; Dietmaier, Wolfgang ; Dietrich, Jörg ; Dudel, Christine ; Hübner, Franz ; Jauch, Tanya ; Drechsel, Elisabeth ; Kleiter, Ingo ; Wismeth, Cäcile ; Zellner, Anton ; Brawanski, Alexander ; Steinbrecher, Andreas ; Marienhagen, Jörg ; Bogdahn, Ulrich

Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma

Hau, Peter, Fabel, Klaus, Baumgart, Ulrike, Rümmele, Petra, Grauer, Oliver, Bock, Annekatrin, Dietmaier, Christopher, Dietmaier, Wolfgang, Dietrich, Jörg, Dudel, Christine, Hübner, Franz, Jauch, Tanya, Drechsel, Elisabeth, Kleiter, Ingo, Wismeth, Cäcile, Zellner, Anton, Brawanski, Alexander, Steinbrecher, Andreas, Marienhagen, Jörg and Bogdahn, Ulrich (2004) Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer 100 (6), pp. 1199-1207.

Date of publication of this fulltext: 21 Jan 2014 11:11
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleCancer
Publisher:JOHN WILEY & SONS INC
Place of Publication:HOBOKEN
Volume:100
Number of Issue or Book Chapter:6
Page Range:pp. 1199-1207
Date2004
InstitutionsMedicine > Lehrstuhl für Neurochirurgie
Medicine > Lehrstuhl für Neurologie
Medicine > Lehrstuhl für Pathologie
Medicine > Abteilung für Nuklearmedizin
Identification Number
ValueType
15022287PubMed ID
10.1002/cncr.20073DOI
Classification
NotationType
AdultMESH
AgedMESH
Antineoplastic Agents/therapeutic useMESH
Antineoplastic Combined Chemotherapy Protocols/therapeutic useMESH
Brain Neoplasms/drug therapyMESH
Doxorubicin/therapeutic useMESH
Drug CarriersMESH
FemaleMESH
Glioma/drug therapyMESH
HumansMESH
ImmunohistochemistryMESH
MaleMESH
Middle AgedMESH
P-Glycoprotein/biosynthesisMESH
Peptides/therapeutic useMESH
Polyethylene Glycols/therapeutic useMESH
Quality of LifeMESH
Survival AnalysisMESH
Tamoxifen/therapeutic useMESH
Tomography, Emission-Computed, Single-PhotonMESH
Treatment OutcomeMESH
KeywordsHIGH-DOSE TAMOXIFEN; QUALITY-OF-LIFE; MALIGNANT GLIOMA; PHASE-II; GLIOBLASTOMA-MULTIFORME; RESPONSE CRITERIA; DRUG-RESISTANCE; BRAIN-TUMORS; CHEMOTHERAPY; TRIAL; anaplastic astrocytoma; glioblastoma; pegylated liposomal doxorubicin; Phase II trial; tamoxifen
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgUnknown
Item ID29344

Export bibliographical data

Owner only: item control page

nach oben